Literature DB >> 2871619

Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.

J A Walsh.   

Abstract

Major problems with a wide array of imperfect tests for diagnosis of amebiasis severely limit the understanding of its magnitude and epidemiology. A greater hindrance is the varied, inconsistent application of existing methods in different areas of the world. The best estimates suggest that probably 480 million people were infected with Entamoeba histolytica and 36 million developed disabling colitis or extraintestinal abscesses in 1981. At least 40 thousand deaths are attributable to amebiasis, and on a global scale, amebiasis likely ranks third among parasitic causes of death, behind only malaria and schistosomiasis. Much remains to be learned of its frequency of occurrence and epidemiology as needed improved diagnostic tools are developed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871619     DOI: 10.1093/clinids/8.2.228

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  174 in total

1.  The cysteine-rich region of the Entamoeba histolytica adherence lectin (170-kilodalton subunit) is sufficient for high-affinity Gal/GalNAc-specific binding in vitro.

Authors:  D R Pillai; P S Wan; Y C Yau; J I Ravdin; K C Kain
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Evidence that hyaluronidase is not involved in tissue invasion of the protozoan parasite Entamoeba histolytica.

Authors:  R Nickel; R Stern; M Leippe
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  Evaluation of a rapid point-of-care fecal antigen detection test for Entamoeba histolytica.

Authors:  Poonum S Korpe; Blake R Stott; Forida Nazib; Mamun Kabir; Rashidul Haque; Joel F Herbein; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

4.  Sequence of a cysteine-rich galactose-specific lectin of Entamoeba histolytica.

Authors:  B J Mann; B E Torian; T S Vedvick; W A Petri
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 5.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 6.  Anti-inflammatory defense mechanisms of Entamoeba histolytica.

Authors:  Raúl Silva-García; Guadalupe Rico-Rosillo
Journal:  Inflamm Res       Date:  2010-10-12       Impact factor: 4.575

Review 7.  Clinical features and management of amebic liver abscess. Experience from 29 patients.

Authors:  T Weinke; W Scherer; U Neuber; M Trautmann
Journal:  Klin Wochenschr       Date:  1989-04-17

8.  Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.

Authors:  A Marinets; T Zhang; N Guillén; P Gounon; B Bohle; U Vollmann; O Scheiner; G Wiedermann; S L Stanley; M Duchêne
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

9.  Molecular modeling on pyruvate phosphate dikinase of Entamoeba histolytica and in silico virtual screening for novel inhibitors.

Authors:  Preyesh Stephen; Ramachandran Vijayan; Audesh Bhat; N Subbarao; R N K Bamezai
Journal:  J Comput Aided Mol Des       Date:  2007-08-21       Impact factor: 3.686

10.  Comparative genomic hybridizations of Entamoeba strains reveal unique genetic fingerprints that correlate with virulence.

Authors:  Preetam H Shah; Ryan C MacFarlane; Dhruva Bhattacharya; John C Matese; Janos Demeter; Suzanne E Stroup; Upinder Singh
Journal:  Eukaryot Cell       Date:  2005-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.